Latest News and Press Releases
Want to stay updated on the latest news?
-
Stephan Crokaert, formerly of NeoMedLight, Abbott, Adagio and Boston Scientific, brings more than 35 years of strategic and commercial experience in life sciencesAllegro prepares to advance lead...
-
Hydrocelin is potentially a first-in-class disease-modifying injectable treatment for osteoarthritisPivotal clinical trial in osteoarthritis patients on track to start in 2025 Liege, Belgium – 4...
-
Clean systemic toxicity profile and no local side-effects following injection Tiny shock absorbing microparticles support and enhance synovial fluidDesigned as potential first-in-class...